LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd. (ProSpec). In the beginning of 2013, LifeMap Sciences will be offering more than a 1000 recombinant proteins and antibodies, many of which are related to stem cell research, such as growth factors, signaling molecules, differentiation factors, hormones, cytokines and chemokines. LifeMap Sciences is the principal marketing and sales arm for BioTime’s cell-based products and related reagents for research use in academia, research hospitals, and biotech and pharma companies. ProSpec’s innovative products will complement the current BioTime research product lines available via the recently launched LifeMap BioReagents™ portal, including PureStem™ human progenitor cell lines, PureStem™ packages, clinical and research grade human embryonic stem cell lines (hES), HyStem® hydrogels, culture media, and cell differentiation kits. LifeMap BioReagents™ offering of BioTime products and the upcoming addition of the ProSpec products reflects the company’s initial execution of a strategy to market a growing catalog of research products to aid scientists in a variety of fields, including stem cell research, developmental biology, mechanisms of various human diseases, drug discovery, and therapeutic discovery and development. LifeMap Sciences holds the exclusive, worldwide license to market GeneCards®( www.genecards.org), with over 12 million page visits per year from hundreds of thousands of unique users worldwide, and MalaCards ( www.malacards.org), and plans to launch LifeMap Discovery™, its database for biomedical and stem cell research, later this quarter. LifeMap BioReagents™ will be integrated with the GeneCards®, MalaCards, and LifeMap Discovery™ databases, thereby providing hundreds of thousands of biomedical researchers accessing these databases a means of identifying reagents that can enhance their research and discovery efforts. These databases currently feature targeted links to the various BioTime PureStem™ human progenitor cell lines, PureStem™ packages, and clinical and research grade human embryonic stem cell lines, and will soon add links to the ProSpec manufactured products. These links enable researchers who access the databases to become familiar with, and purchase, products that relate directly to the types of genes, cells, or diseases that they are studying and can assist them in various research projects. “We are pleased to establish this distribution relationship with ProSpec,” stated Yaron Guan-Golan, Head of Marketing at LifeMap Sciences. “This agreement represents a significant step for our LifeMap BioReagents portal, enabling us to place high quality recombinant proteins in the hands of our research community user base, and increasing our product portfolio and brand awareness.” About LifeMap Sciences, Inc. LifeMap Sciences’ ( www.lifemapsc.com) core technology and business is based on its integrated database suite, the discovery platform for biomedical and stem cell research. This platform includes GeneCards®, the leading human gene database; LifeMap Discovery™, the database of embryonic development, stem cell research, and regenerative medicine; and MalaCards, the human disease database. LifeMap Sciences also markets PanDaTox, an innovative, recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products. In addition to database offerings, LifeMap Sciences is BioTime’s principal marketing subsidiary for research products, including PureStem™ human progenitor cell lines, GMP human embryonic stem (hES) cell lines, ESpan™ growth media for progenitor cell lines, and cell differentiation media for non-therapeutic uses, via its LifeMap BioReagents™ portal. LifeMap Sciences will utilize its databases as part of its online marketing strategy to reach life sciences researchers at biotech and pharmaceutical companies and at academic institutions and research hospitals worldwide. In a therapeutic discovery collaboration with BioTime, LifeMap’s scientists utilize LifeMap’s proprietary platform, including LifeMap Discovery™, its stem cell database along with the GeneCards® and MalaCards integrated database suite, to aid in the development of BioTime’s proprietary PureStem™ human progenitor cell lines into products for the treatment of human diseases, especially degenerative diseases that might be treatable with cell replacement therapies. The LifeMap Discovery™ platform will be used to select the progenitor cell lines that are most likely to facilitate the development of cell-based regenerative medicine therapies for a wide range of diseases. About ProSpec-Tany TechnoGene Ltd. ProSpec (Protein-Specialists) is a leading biotechnology company having over 19 years of experience specializing in production of bacterial-derived recombinant proteins. ProSpec produces a wide array of Cytokines, Growth Factors, Chemokines, Hormones, Enzymes, Viral Antigens and many other recombinant proteins.
Investors considering a purchase of BioTime, Inc. shares, but tentative about paying the going market price of $3.26/share, might benefit from considering selling puts among the alternative strategies at their disposal.